OpenURL Connection Search

Select item for more details and to access through your institution.

Safety and financial analysis of outpatient dose-adjusted EPOCH for B-cell lymphoma at a tertiary comprehensive cancer center.
Published in:
Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1684, doi. 10.1177/1078155220967080
By:
- Li, Wenhui;
- Richter, Katherine A;
- Tobon, Katherine A;
- McCarthy, Kevin T;
- Kubal, Timothy E
Publication type:
Article
Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
Published in:
Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 563, doi. 10.1002/cpt.1641
By:
- Hicks, J. Kevin;
- Quilitz, Rod E.;
- Komrokji, Rami S.;
- Kubal, Timothy E.;
- Lancet, Jeffrey E.;
- Pasikhova, Yanina;
- Qin, Dahui;
- So, Wonhee;
- Caceres, Gisela;
- Kelly, Kerry;
- Salchert, Yasmina S.;
- Shahbazian, Kevin;
- Abbas‐Aghababazadeh, Farnoosh;
- Fridley, Brooke L.;
- Velez, Ana P.;
- McLeod, Howard L.;
- Greene, John N.
Publication type:
Article
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
Published in:
American Journal of Hematology, 2017, v. 92, n. 3, p. 232, doi. 10.1002/ajh.24627
By:
- Griffin, Patrick T.;
- Komrokji, Rami S.;
- Sweet, Kendra;
- Al Ali, Najla H.;
- Padron, Eric;
- Kubal, Timothy E.;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article

Found: 3

Safety and financial analysis of outpatient dose-adjusted EPOCH for B-cell lymphoma at a tertiary comprehensive cancer center.

Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.

Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.